Effective immobiliization of Candida auris by SecurePortIV
Extract:
“The objective of this white paper is to demonstrate the evidence that Candida auris can effectively be immobilized by SecurePortIV® Catheter Securement Adhesive. SecurePortIV®, approved by the FDA in Sept. 2017, was the first and only catheter securement adhesive, which was manufactured by Adhezion Biomedical, LLC, a subsidiary of the H.B. Fuller. SecurePortIV is intended to be a film forming securement and sealant at the point of vascular access catheter skin entry. The use of SecurePortIV® can significantly reduce various failures and complications associated with catheter insertion including dislodgement, phlebitis, infiltration and catheter-related bloodstream infections.”